Skip to main content
. 2018 Dec 28;12:291–301. doi: 10.2147/OTT.S190118

Figure 6.

Figure 6

Effect of TLR9 to chemoresistance by hypoxia.

Notes: (A) TLR9 agonist CpG ODN2006 reduces the sensitivity of SKOV3 to cisplatin; (B) TLR9 antagonist attenuates hypoxia supernatant-induced cell resistance to cisplatin. *P<0.01, compared with control group.

Abbreviations: HICR, hypoxia-induced chemoresistance; CQ, chloroquine.